# US 2008/0305085 A1 · Compositions And Methods For Stem Cell Expansion

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2008/0305085 A1
- Document ID: US20080305085A1
- Status: Published application
- Kind: A1
- Application number: 11/791,147
- Filed: 2005-11-18
- Published: 2008-12-11
- Earliest claimed: 2004-11-19
- Inventors: David T. Scadden; Sebastian Stier
- Web page: https://patentgrep.com/patent/US20080305085A1

## CPC

- C12N 5/0654: {Osteocytes, Osteoblasts, Odontocytes; Bones, Teeth}
- A61P 31/00: Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- C12N 5/0647: {Haematopoietic stem cells; Uncommitted or multipotent progenitors}
- G01N 33/6887: {from muscle, cartilage or connective tissue}
- C12N 2501/125: Stem cell factor [SCF], c-kit ligand [KL]
- C12N 2501/145: Thrombopoietin [TPO]
- C12N 2501/23: Interleukins [IL]
- C12N 2501/26: Flt-3 ligand (CD135L, flk-2 ligand)
- G01N 2500/00: Screening for compounds of potential therapeutic value
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

The present invention features methods and compositions that are useful for promoting stem cell survival and expansion. In addition, the invention also provides compositions and methods for the treatment of neoplasia.

## Claims

### Claim 1

A method of promoting stem cell survival or generation, the method comprising
a) contacting a stem cell or stem cell progenitor and a support cell that expresses osteopontin (OPN) with an OPN inhibitor; and
b) growing the stem cell or stem cell progenitor in the presence of the support cell, to thereby promote stem cell survival or generation.

### Claim 2 (depends on 1)

The method of claim 1, wherein the stem cell is selected from the group consisting of a mesenchymal, skin, neural, intestinal, liver, cardiac, prostate, mammary, kidney, pancreatic, retinal and lung stem cell.

### Claim 3 (depends on 2)

The method of claim 2, wherein the stem cell is a hematopoietic stem cell.

### Claim 4 (depends on 1)

The method of claim 1, wherein the support cell is a cellular component of a stem cell niche.

### Claim 5 (depends on 4)

The method of claim 4, wherein the support cell is an osteoblast.

### Claim 6 (depends on 1)

The method of claim 1, wherein the generation is by stem cell self-renewal.

### Claim 7 (depends on 1)

The method of claim 1, wherein the generation is by proliferation or differentiation of the stem cell progenitor.

### Claim 8 (depends on 1)

The method of claim 1, wherein the method reduces apoptosis.

### Claim 9 (depends on 1)

The method of claim 1, wherein the method is carried out in vivo.

### Claim 10 (depends on 1)

The method of claim 1, wherein the method is carried out in vitro.

### Claim 11

A method of promoting stem cell survival or generation, the method comprising
a) contacting a stem cell or stem cell progenitor that expresses osteopontin (OPN) with an OPN inhibitor; and
b) growing the stem cell or stem cell progenitor, to thereby promote stem cell survival or generation.

### Claim 12 (depends on 1)

The method of claim 1 wherein the stem cell is a hematopoietic stem cell.

### Claim at position 13

13-29. (canceled)

### Claim 30

A method of increasing the number of self-renewing stem cells in a subject in need thereof, the method comprising the steps of:
contacting an isolated population of cells that comprises at least stem cells and support cells with an OPN inhibitor; and
administering the cells to the subject, thereby increasing the amount of self-renewing stem cells in the subject.

### Claim at position 15

31-48. (canceled)

### Claim 49

A method for enhancing engraftment of a stem cell into a tissue of a subject, the method comprising
a) contacting a tissue of a subject with an OPN inhibitor; and
b) providing a stem cell to the tissue, thereby enhancing engraftment of the stem cell into the tissue of the subject.

### Claim at position 17

50-54. (canceled)

### Claim 55

A method of modulating a stem cell niche, the method comprising contacting the niche with an OPN inhibitor, thereby modulating the stem cell niche.

### Claim at position 19

56-62. (canceled)

### Claim 63

A method for enhancing the hematopoietic stem cell-proliferating activity of a stromal cell comprising contacting the stromal cell with an OPN inhibitor.

### Claim at position 21

64-66. (canceled)

### Claim 67 (depends on 49)

The method of claim 49, wherein the stem cell is a hematopoietic stem cell.

### Claim at position 23

68-84. (canceled)

### Claim 85

A method of inhibiting the survival or proliferation of a neoplastic cell, the method comprising contacting a neoplastic cell with an effective amount of an OPN polypeptide or analog thereof, to thereby inhibit the survival or proliferation of the neoplastic cell.

### Claim 86

A method of inducing apoptosis in a neoplastic cell, the method comprising contacting a neoplastic cell with an effective amount of an OPN polypeptide or analog thereof, to thereby induce apoptosis in the neoplastic cell.

### Claim at position 26

87-88. (canceled)

### Claim 89

A method of treating or preventing a neoplasia in a subject in need thereof, the method comprising contacting a cell of the subject with a pharmaceutical composition comprising an effective amount of an OPN polypeptide or analog thereof, to thereby treat or prevent a neoplasia.

### Claim 90

(canceled)

### Claim 91

A method of treating or preventing a neoplasia in a subject in need thereof, the method comprising contacting a cell of the subject with a pharmaceutical composition comprising an effective amount of a compound that increases the expression of an OPN polypeptide or nucleic acid molecule, to thereby treat or prevent a neoplasia in the subject.

### Claim at position 30

92-101. (canceled)
